nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Imiquimod—skin cancer	0.175	0.292	CbGbCtD
Budesonide—CYP3A4—Temozolomide—skin cancer	0.175	0.292	CbGbCtD
Budesonide—CYP3A4—Vismodegib—skin cancer	0.121	0.202	CbGbCtD
Budesonide—CYP3A4—Vemurafenib—skin cancer	0.096	0.16	CbGbCtD
Budesonide—CYP3A4—Docetaxel—skin cancer	0.033	0.0548	CbGbCtD
Budesonide—Fluocinonide—SMO—skin cancer	0.00564	0.837	CrCbGaD
Budesonide—Pruritus—Vemurafenib—skin cancer	0.000511	0.0013	CcSEcCtD
Budesonide—Connective tissue disorder—Temozolomide—skin cancer	0.000511	0.0013	CcSEcCtD
Budesonide—Urethral disorder—Temozolomide—skin cancer	0.00051	0.0013	CcSEcCtD
Budesonide—Alopecia—Dactinomycin—skin cancer	0.000508	0.0013	CcSEcCtD
Budesonide—Feeling abnormal—Imiquimod—skin cancer	0.000508	0.0013	CcSEcCtD
Budesonide—Gastrointestinal pain—Imiquimod—skin cancer	0.000504	0.00129	CcSEcCtD
Budesonide—Epistaxis—Fluorouracil—skin cancer	0.000503	0.00128	CcSEcCtD
Budesonide—Visual impairment—Temozolomide—skin cancer	0.000501	0.00128	CcSEcCtD
Budesonide—Sinusitis—Fluorouracil—skin cancer	0.000501	0.00128	CcSEcCtD
Budesonide—Ill-defined disorder—Bleomycin—skin cancer	0.000498	0.00127	CcSEcCtD
Budesonide—Anaemia—Bleomycin—skin cancer	0.000496	0.00126	CcSEcCtD
Budesonide—Diarrhoea—Vemurafenib—skin cancer	0.000495	0.00126	CcSEcCtD
Budesonide—Migraine—Docetaxel—skin cancer	0.000492	0.00125	CcSEcCtD
Budesonide—Urticaria—Imiquimod—skin cancer	0.00049	0.00125	CcSEcCtD
Budesonide—Abdominal pain—Imiquimod—skin cancer	0.000487	0.00124	CcSEcCtD
Budesonide—Body temperature increased—Imiquimod—skin cancer	0.000487	0.00124	CcSEcCtD
Budesonide—Eye disorder—Temozolomide—skin cancer	0.000486	0.00124	CcSEcCtD
Budesonide—Malaise—Bleomycin—skin cancer	0.000484	0.00123	CcSEcCtD
Budesonide—Flushing—Temozolomide—skin cancer	0.000483	0.00123	CcSEcCtD
Budesonide—Cardiac disorder—Temozolomide—skin cancer	0.000483	0.00123	CcSEcCtD
Budesonide—Haemoglobin—Fluorouracil—skin cancer	0.000482	0.00123	CcSEcCtD
Budesonide—Rhinitis—Fluorouracil—skin cancer	0.00048	0.00122	CcSEcCtD
Budesonide—Triamcinolone—PTGS2—skin cancer	0.000479	0.0711	CrCbGaD
Budesonide—Haemorrhage—Fluorouracil—skin cancer	0.000479	0.00122	CcSEcCtD
Budesonide—Dizziness—Vemurafenib—skin cancer	0.000478	0.00122	CcSEcCtD
Budesonide—Pharyngitis—Fluorouracil—skin cancer	0.000475	0.00121	CcSEcCtD
Budesonide—Angiopathy—Temozolomide—skin cancer	0.000472	0.0012	CcSEcCtD
Budesonide—Immune system disorder—Temozolomide—skin cancer	0.00047	0.0012	CcSEcCtD
Budesonide—Mediastinal disorder—Temozolomide—skin cancer	0.000469	0.00119	CcSEcCtD
Budesonide—Cough—Bleomycin—skin cancer	0.000468	0.00119	CcSEcCtD
Budesonide—Ill-defined disorder—Dactinomycin—skin cancer	0.000464	0.00118	CcSEcCtD
Budesonide—Anaemia—Dactinomycin—skin cancer	0.000463	0.00118	CcSEcCtD
Budesonide—Vomiting—Vemurafenib—skin cancer	0.00046	0.00117	CcSEcCtD
Budesonide—Alopecia—Temozolomide—skin cancer	0.000459	0.00117	CcSEcCtD
Budesonide—Chest pain—Bleomycin—skin cancer	0.000457	0.00116	CcSEcCtD
Budesonide—Myalgia—Bleomycin—skin cancer	0.000457	0.00116	CcSEcCtD
Budesonide—Abdominal pain upper—Docetaxel—skin cancer	0.000457	0.00116	CcSEcCtD
Budesonide—Rash—Vemurafenib—skin cancer	0.000456	0.00116	CcSEcCtD
Budesonide—Mental disorder—Temozolomide—skin cancer	0.000456	0.00116	CcSEcCtD
Budesonide—Dermatitis—Vemurafenib—skin cancer	0.000455	0.00116	CcSEcCtD
Budesonide—Hypersensitivity—Imiquimod—skin cancer	0.000454	0.00116	CcSEcCtD
Budesonide—Headache—Vemurafenib—skin cancer	0.000453	0.00115	CcSEcCtD
Budesonide—Malnutrition—Temozolomide—skin cancer	0.000453	0.00115	CcSEcCtD
Budesonide—Breast disorder—Docetaxel—skin cancer	0.000452	0.00115	CcSEcCtD
Budesonide—Discomfort—Bleomycin—skin cancer	0.000451	0.00115	CcSEcCtD
Budesonide—Malaise—Dactinomycin—skin cancer	0.000451	0.00115	CcSEcCtD
Budesonide—Cramp muscle—Docetaxel—skin cancer	0.00045	0.00115	CcSEcCtD
Budesonide—Nasopharyngitis—Docetaxel—skin cancer	0.000447	0.00114	CcSEcCtD
Budesonide—Dysgeusia—Temozolomide—skin cancer	0.000443	0.00113	CcSEcCtD
Budesonide—Asthenia—Imiquimod—skin cancer	0.000442	0.00113	CcSEcCtD
Budesonide—Confusional state—Bleomycin—skin cancer	0.000442	0.00113	CcSEcCtD
Budesonide—Anaphylactic shock—Bleomycin—skin cancer	0.000438	0.00112	CcSEcCtD
Budesonide—Back pain—Temozolomide—skin cancer	0.000438	0.00112	CcSEcCtD
Budesonide—Pruritus—Imiquimod—skin cancer	0.000436	0.00111	CcSEcCtD
Budesonide—Infection—Bleomycin—skin cancer	0.000435	0.00111	CcSEcCtD
Budesonide—Nausea—Vemurafenib—skin cancer	0.000429	0.00109	CcSEcCtD
Budesonide—Vision blurred—Temozolomide—skin cancer	0.000427	0.00109	CcSEcCtD
Budesonide—Myalgia—Dactinomycin—skin cancer	0.000426	0.00109	CcSEcCtD
Budesonide—Bronchospasm—Docetaxel—skin cancer	0.000425	0.00108	CcSEcCtD
Budesonide—Tremor—Temozolomide—skin cancer	0.000424	0.00108	CcSEcCtD
Budesonide—Alopecia—Fluorouracil—skin cancer	0.000423	0.00108	CcSEcCtD
Budesonide—Diarrhoea—Imiquimod—skin cancer	0.000422	0.00108	CcSEcCtD
Budesonide—Discomfort—Dactinomycin—skin cancer	0.000421	0.00107	CcSEcCtD
Budesonide—Ill-defined disorder—Temozolomide—skin cancer	0.00042	0.00107	CcSEcCtD
Budesonide—Anaemia—Temozolomide—skin cancer	0.000418	0.00107	CcSEcCtD
Budesonide—Anorexia—Bleomycin—skin cancer	0.000417	0.00106	CcSEcCtD
Budesonide—Agitation—Temozolomide—skin cancer	0.000416	0.00106	CcSEcCtD
Budesonide—Angioedema—Temozolomide—skin cancer	0.000414	0.00105	CcSEcCtD
Budesonide—Malaise—Temozolomide—skin cancer	0.000408	0.00104	CcSEcCtD
Budesonide—Dizziness—Imiquimod—skin cancer	0.000408	0.00104	CcSEcCtD
Budesonide—Vertigo—Temozolomide—skin cancer	0.000407	0.00104	CcSEcCtD
Budesonide—Infection—Dactinomycin—skin cancer	0.000406	0.00103	CcSEcCtD
Budesonide—Palpitations—Temozolomide—skin cancer	0.0004	0.00102	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000399	0.00102	CcSEcCtD
Budesonide—Cough—Temozolomide—skin cancer	0.000395	0.00101	CcSEcCtD
Budesonide—Paraesthesia—Bleomycin—skin cancer	0.000393	0.001	CcSEcCtD
Budesonide—Weight increased—Docetaxel—skin cancer	0.000393	0.001	CcSEcCtD
Budesonide—Vision blurred—Fluorouracil—skin cancer	0.000393	0.001	CcSEcCtD
Budesonide—Betamethasone—PTGS2—skin cancer	0.000392	0.0582	CrCbGaD
Budesonide—Vomiting—Imiquimod—skin cancer	0.000392	0.000999	CcSEcCtD
Budesonide—Hypertension—Temozolomide—skin cancer	0.000391	0.000996	CcSEcCtD
Budesonide—Dyspnoea—Bleomycin—skin cancer	0.00039	0.000995	CcSEcCtD
Budesonide—Anorexia—Dactinomycin—skin cancer	0.000389	0.000993	CcSEcCtD
Budesonide—Rash—Imiquimod—skin cancer	0.000389	0.000991	CcSEcCtD
Budesonide—Dermatitis—Imiquimod—skin cancer	0.000388	0.00099	CcSEcCtD
Budesonide—Headache—Imiquimod—skin cancer	0.000386	0.000985	CcSEcCtD
Budesonide—Anaemia—Fluorouracil—skin cancer	0.000385	0.000983	CcSEcCtD
Budesonide—Myalgia—Temozolomide—skin cancer	0.000385	0.000982	CcSEcCtD
Budesonide—Arthralgia—Temozolomide—skin cancer	0.000385	0.000982	CcSEcCtD
Budesonide—Infestation NOS—Docetaxel—skin cancer	0.000385	0.000982	CcSEcCtD
Budesonide—Infestation—Docetaxel—skin cancer	0.000385	0.000982	CcSEcCtD
Budesonide—Anxiety—Temozolomide—skin cancer	0.000384	0.000979	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000383	0.000976	CcSEcCtD
Budesonide—Discomfort—Temozolomide—skin cancer	0.000381	0.000971	CcSEcCtD
Budesonide—Decreased appetite—Bleomycin—skin cancer	0.000381	0.000971	CcSEcCtD
Budesonide—Dry mouth—Temozolomide—skin cancer	0.000377	0.000961	CcSEcCtD
Budesonide—Pain—Bleomycin—skin cancer	0.000374	0.000955	CcSEcCtD
Budesonide—Conjunctivitis—Docetaxel—skin cancer	0.000374	0.000955	CcSEcCtD
Budesonide—Confusional state—Temozolomide—skin cancer	0.000372	0.00095	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000372	0.000949	CcSEcCtD
Budesonide—Anaphylactic shock—Temozolomide—skin cancer	0.000369	0.000942	CcSEcCtD
Budesonide—Infection—Temozolomide—skin cancer	0.000367	0.000936	CcSEcCtD
Budesonide—Nausea—Imiquimod—skin cancer	0.000366	0.000934	CcSEcCtD
Budesonide—Epistaxis—Docetaxel—skin cancer	0.000363	0.000926	CcSEcCtD
Budesonide—Nervous system disorder—Temozolomide—skin cancer	0.000362	0.000924	CcSEcCtD
Budesonide—Feeling abnormal—Bleomycin—skin cancer	0.000361	0.00092	CcSEcCtD
Budesonide—Skin disorder—Temozolomide—skin cancer	0.000359	0.000915	CcSEcCtD
Budesonide—Hyperhidrosis—Temozolomide—skin cancer	0.000357	0.000911	CcSEcCtD
Budesonide—Myalgia—Fluorouracil—skin cancer	0.000355	0.000905	CcSEcCtD
Budesonide—Chest pain—Fluorouracil—skin cancer	0.000355	0.000905	CcSEcCtD
Budesonide—Decreased appetite—Dactinomycin—skin cancer	0.000355	0.000905	CcSEcCtD
Budesonide—Fatigue—Dactinomycin—skin cancer	0.000352	0.000898	CcSEcCtD
Budesonide—Anorexia—Temozolomide—skin cancer	0.000352	0.000898	CcSEcCtD
Budesonide—Discomfort—Fluorouracil—skin cancer	0.000351	0.000894	CcSEcCtD
Budesonide—Pain—Dactinomycin—skin cancer	0.000349	0.00089	CcSEcCtD
Budesonide—Urticaria—Bleomycin—skin cancer	0.000348	0.000887	CcSEcCtD
Budesonide—Haemoglobin—Docetaxel—skin cancer	0.000348	0.000886	CcSEcCtD
Budesonide—Rhinitis—Docetaxel—skin cancer	0.000347	0.000884	CcSEcCtD
Budesonide—Body temperature increased—Bleomycin—skin cancer	0.000346	0.000883	CcSEcCtD
Budesonide—Haemorrhage—Docetaxel—skin cancer	0.000346	0.000882	CcSEcCtD
Budesonide—Confusional state—Fluorouracil—skin cancer	0.000343	0.000875	CcSEcCtD
Budesonide—Pharyngitis—Docetaxel—skin cancer	0.000343	0.000875	CcSEcCtD
Budesonide—Urinary tract disorder—Docetaxel—skin cancer	0.000341	0.000871	CcSEcCtD
Budesonide—Oedema peripheral—Docetaxel—skin cancer	0.000341	0.000868	CcSEcCtD
Budesonide—Anaphylactic shock—Fluorouracil—skin cancer	0.00034	0.000868	CcSEcCtD
Budesonide—Connective tissue disorder—Docetaxel—skin cancer	0.00034	0.000866	CcSEcCtD
Budesonide—Urethral disorder—Docetaxel—skin cancer	0.000339	0.000864	CcSEcCtD
Budesonide—Infection—Fluorouracil—skin cancer	0.000338	0.000862	CcSEcCtD
Budesonide—Feeling abnormal—Dactinomycin—skin cancer	0.000337	0.000858	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000337	0.000858	CcSEcCtD
Budesonide—Insomnia—Temozolomide—skin cancer	0.000334	0.000852	CcSEcCtD
Budesonide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000334	0.000852	CcSEcCtD
Budesonide—Nervous system disorder—Fluorouracil—skin cancer	0.000334	0.000851	CcSEcCtD
Budesonide—Visual impairment—Docetaxel—skin cancer	0.000333	0.00085	CcSEcCtD
Budesonide—Tachycardia—Fluorouracil—skin cancer	0.000332	0.000847	CcSEcCtD
Budesonide—Paraesthesia—Temozolomide—skin cancer	0.000332	0.000846	CcSEcCtD
Budesonide—Dyspnoea—Temozolomide—skin cancer	0.000329	0.00084	CcSEcCtD
Budesonide—Somnolence—Temozolomide—skin cancer	0.000328	0.000837	CcSEcCtD
Budesonide—Dyspepsia—Temozolomide—skin cancer	0.000325	0.000829	CcSEcCtD
Budesonide—Anorexia—Fluorouracil—skin cancer	0.000324	0.000827	CcSEcCtD
Budesonide—Eye disorder—Docetaxel—skin cancer	0.000323	0.000824	CcSEcCtD
Budesonide—Body temperature increased—Dactinomycin—skin cancer	0.000323	0.000823	CcSEcCtD
Budesonide—Abdominal pain—Dactinomycin—skin cancer	0.000323	0.000823	CcSEcCtD
Budesonide—Hypersensitivity—Bleomycin—skin cancer	0.000323	0.000823	CcSEcCtD
Budesonide—Decreased appetite—Temozolomide—skin cancer	0.000321	0.000819	CcSEcCtD
Budesonide—Flushing—Docetaxel—skin cancer	0.000321	0.000818	CcSEcCtD
Budesonide—Cardiac disorder—Docetaxel—skin cancer	0.000321	0.000818	CcSEcCtD
Budesonide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000319	0.000813	CcSEcCtD
Budesonide—Fatigue—Temozolomide—skin cancer	0.000318	0.000812	CcSEcCtD
Budesonide—Constipation—Temozolomide—skin cancer	0.000316	0.000805	CcSEcCtD
Budesonide—Pain—Temozolomide—skin cancer	0.000316	0.000805	CcSEcCtD
Budesonide—Asthenia—Bleomycin—skin cancer	0.000314	0.000801	CcSEcCtD
Budesonide—Angiopathy—Docetaxel—skin cancer	0.000314	0.0008	CcSEcCtD
Budesonide—Immune system disorder—Docetaxel—skin cancer	0.000312	0.000796	CcSEcCtD
Budesonide—Mediastinal disorder—Docetaxel—skin cancer	0.000312	0.000795	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00031	0.000791	CcSEcCtD
Budesonide—Pruritus—Bleomycin—skin cancer	0.00031	0.00079	CcSEcCtD
Budesonide—Insomnia—Fluorouracil—skin cancer	0.000308	0.000785	CcSEcCtD
Budesonide—Paraesthesia—Fluorouracil—skin cancer	0.000306	0.000779	CcSEcCtD
Budesonide—Alopecia—Docetaxel—skin cancer	0.000306	0.000779	CcSEcCtD
Budesonide—Feeling abnormal—Temozolomide—skin cancer	0.000304	0.000776	CcSEcCtD
Budesonide—Dyspnoea—Fluorouracil—skin cancer	0.000303	0.000774	CcSEcCtD
Budesonide—Mental disorder—Docetaxel—skin cancer	0.000303	0.000772	CcSEcCtD
Budesonide—Somnolence—Fluorouracil—skin cancer	0.000303	0.000771	CcSEcCtD
Budesonide—Gastrointestinal pain—Temozolomide—skin cancer	0.000302	0.00077	CcSEcCtD
Budesonide—Malnutrition—Docetaxel—skin cancer	0.000301	0.000767	CcSEcCtD
Budesonide—Hypersensitivity—Dactinomycin—skin cancer	0.000301	0.000767	CcSEcCtD
Budesonide—Dyspepsia—Fluorouracil—skin cancer	0.0003	0.000764	CcSEcCtD
Budesonide—Decreased appetite—Fluorouracil—skin cancer	0.000296	0.000754	CcSEcCtD
Budesonide—Dysgeusia—Docetaxel—skin cancer	0.000295	0.000752	CcSEcCtD
Budesonide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000294	0.000749	CcSEcCtD
Budesonide—Urticaria—Temozolomide—skin cancer	0.000293	0.000748	CcSEcCtD
Budesonide—Asthenia—Dactinomycin—skin cancer	0.000293	0.000747	CcSEcCtD
Budesonide—Body temperature increased—Temozolomide—skin cancer	0.000292	0.000745	CcSEcCtD
Budesonide—Abdominal pain—Temozolomide—skin cancer	0.000292	0.000745	CcSEcCtD
Budesonide—Back pain—Docetaxel—skin cancer	0.000291	0.000742	CcSEcCtD
Budesonide—Pain—Fluorouracil—skin cancer	0.000291	0.000742	CcSEcCtD
Budesonide—Muscle spasms—Docetaxel—skin cancer	0.000289	0.000738	CcSEcCtD
Budesonide—Feeling abnormal—Fluorouracil—skin cancer	0.00028	0.000715	CcSEcCtD
Budesonide—Diarrhoea—Dactinomycin—skin cancer	0.000279	0.000712	CcSEcCtD
Budesonide—Vomiting—Bleomycin—skin cancer	0.000278	0.00071	CcSEcCtD
Budesonide—Anaemia—Docetaxel—skin cancer	0.000278	0.000709	CcSEcCtD
Budesonide—Rash—Bleomycin—skin cancer	0.000276	0.000704	CcSEcCtD
Budesonide—Dermatitis—Bleomycin—skin cancer	0.000276	0.000703	CcSEcCtD
Budesonide—Hypersensitivity—Temozolomide—skin cancer	0.000272	0.000694	CcSEcCtD
Budesonide—Urticaria—Fluorouracil—skin cancer	0.00027	0.000689	CcSEcCtD
Budesonide—Syncope—Docetaxel—skin cancer	0.00027	0.000688	CcSEcCtD
Budesonide—Body temperature increased—Fluorouracil—skin cancer	0.000269	0.000686	CcSEcCtD
Budesonide—Palpitations—Docetaxel—skin cancer	0.000266	0.000678	CcSEcCtD
Budesonide—Asthenia—Temozolomide—skin cancer	0.000265	0.000676	CcSEcCtD
Budesonide—Loss of consciousness—Docetaxel—skin cancer	0.000265	0.000675	CcSEcCtD
Budesonide—Cough—Docetaxel—skin cancer	0.000263	0.00067	CcSEcCtD
Budesonide—Pruritus—Temozolomide—skin cancer	0.000261	0.000666	CcSEcCtD
Budesonide—Nausea—Bleomycin—skin cancer	0.00026	0.000663	CcSEcCtD
Budesonide—Hypertension—Docetaxel—skin cancer	0.00026	0.000663	CcSEcCtD
Budesonide—Vomiting—Dactinomycin—skin cancer	0.00026	0.000662	CcSEcCtD
Budesonide—Rash—Dactinomycin—skin cancer	0.000258	0.000657	CcSEcCtD
Budesonide—Chest pain—Docetaxel—skin cancer	0.000256	0.000653	CcSEcCtD
Budesonide—Arthralgia—Docetaxel—skin cancer	0.000256	0.000653	CcSEcCtD
Budesonide—Myalgia—Docetaxel—skin cancer	0.000256	0.000653	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000254	0.000649	CcSEcCtD
Budesonide—Diarrhoea—Temozolomide—skin cancer	0.000253	0.000644	CcSEcCtD
Budesonide—Hypersensitivity—Fluorouracil—skin cancer	0.000251	0.000639	CcSEcCtD
Budesonide—Dry mouth—Docetaxel—skin cancer	0.000251	0.000639	CcSEcCtD
Budesonide—Confusional state—Docetaxel—skin cancer	0.000248	0.000632	CcSEcCtD
Budesonide—Anaphylactic shock—Docetaxel—skin cancer	0.000246	0.000626	CcSEcCtD
Budesonide—Dizziness—Temozolomide—skin cancer	0.000244	0.000623	CcSEcCtD
Budesonide—Infection—Docetaxel—skin cancer	0.000244	0.000622	CcSEcCtD
Budesonide—Nausea—Dactinomycin—skin cancer	0.000243	0.000619	CcSEcCtD
Budesonide—Shock—Docetaxel—skin cancer	0.000242	0.000616	CcSEcCtD
Budesonide—Nervous system disorder—Docetaxel—skin cancer	0.000241	0.000614	CcSEcCtD
Budesonide—Pruritus—Fluorouracil—skin cancer	0.000241	0.000614	CcSEcCtD
Budesonide—Tachycardia—Docetaxel—skin cancer	0.00024	0.000611	CcSEcCtD
Budesonide—Skin disorder—Docetaxel—skin cancer	0.000239	0.000608	CcSEcCtD
Budesonide—Vomiting—Temozolomide—skin cancer	0.000235	0.000599	CcSEcCtD
Budesonide—Anorexia—Docetaxel—skin cancer	0.000234	0.000597	CcSEcCtD
Budesonide—Rash—Temozolomide—skin cancer	0.000233	0.000594	CcSEcCtD
Budesonide—Diarrhoea—Fluorouracil—skin cancer	0.000233	0.000594	CcSEcCtD
Budesonide—Dermatitis—Temozolomide—skin cancer	0.000233	0.000593	CcSEcCtD
Budesonide—Headache—Temozolomide—skin cancer	0.000231	0.00059	CcSEcCtD
Budesonide—Dexamethasone—PTGS2—skin cancer	0.000228	0.0339	CrCbGaD
Budesonide—Dizziness—Fluorouracil—skin cancer	0.000225	0.000574	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000224	0.000571	CcSEcCtD
Budesonide—Insomnia—Docetaxel—skin cancer	0.000222	0.000567	CcSEcCtD
Budesonide—Paraesthesia—Docetaxel—skin cancer	0.000221	0.000562	CcSEcCtD
Budesonide—Nausea—Temozolomide—skin cancer	0.000219	0.000559	CcSEcCtD
Budesonide—Dyspnoea—Docetaxel—skin cancer	0.000219	0.000558	CcSEcCtD
Budesonide—Somnolence—Docetaxel—skin cancer	0.000218	0.000557	CcSEcCtD
Budesonide—Vomiting—Fluorouracil—skin cancer	0.000216	0.000552	CcSEcCtD
Budesonide—Dyspepsia—Docetaxel—skin cancer	0.000216	0.000551	CcSEcCtD
Budesonide—Rash—Fluorouracil—skin cancer	0.000215	0.000547	CcSEcCtD
Budesonide—Dermatitis—Fluorouracil—skin cancer	0.000214	0.000547	CcSEcCtD
Budesonide—Decreased appetite—Docetaxel—skin cancer	0.000214	0.000544	CcSEcCtD
Budesonide—Headache—Fluorouracil—skin cancer	0.000213	0.000544	CcSEcCtD
Budesonide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000212	0.000541	CcSEcCtD
Budesonide—Fatigue—Docetaxel—skin cancer	0.000212	0.00054	CcSEcCtD
Budesonide—Pain—Docetaxel—skin cancer	0.00021	0.000536	CcSEcCtD
Budesonide—Constipation—Docetaxel—skin cancer	0.00021	0.000536	CcSEcCtD
Budesonide—Feeling abnormal—Docetaxel—skin cancer	0.000202	0.000516	CcSEcCtD
Budesonide—Nausea—Fluorouracil—skin cancer	0.000202	0.000515	CcSEcCtD
Budesonide—Gastrointestinal pain—Docetaxel—skin cancer	0.000201	0.000512	CcSEcCtD
Budesonide—Body temperature increased—Docetaxel—skin cancer	0.000194	0.000495	CcSEcCtD
Budesonide—Abdominal pain—Docetaxel—skin cancer	0.000194	0.000495	CcSEcCtD
Budesonide—Hypersensitivity—Docetaxel—skin cancer	0.000181	0.000461	CcSEcCtD
Budesonide—Asthenia—Docetaxel—skin cancer	0.000176	0.000449	CcSEcCtD
Budesonide—Pruritus—Docetaxel—skin cancer	0.000174	0.000443	CcSEcCtD
Budesonide—Diarrhoea—Docetaxel—skin cancer	0.000168	0.000429	CcSEcCtD
Budesonide—Dizziness—Docetaxel—skin cancer	0.000162	0.000414	CcSEcCtD
Budesonide—Vomiting—Docetaxel—skin cancer	0.000156	0.000398	CcSEcCtD
Budesonide—Rash—Docetaxel—skin cancer	0.000155	0.000395	CcSEcCtD
Budesonide—Dermatitis—Docetaxel—skin cancer	0.000155	0.000395	CcSEcCtD
Budesonide—Headache—Docetaxel—skin cancer	0.000154	0.000392	CcSEcCtD
Budesonide—Nausea—Docetaxel—skin cancer	0.000146	0.000372	CcSEcCtD
